Pharma News

 

 

academics

 

Clinical research courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration
    23 September 2024

    FDA Approves Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration

    The U.S. Food and Drug Administration approved FluMist for self- or caregiver-administration. FluMist is approved for the prevention of influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age. FluMist is sprayed into the nose and has been used safely and effectively for many years. It was initially approved by the FDA in 2003 for use in individuals 5 through 49 years of age, and in 2007, the FDA approved the use of FluMist to include children 2 through 5 years of age.

  • 23 September 2024
    Sarclisa approved in the US as the first anti-CD38 therapy
    The US Food and Drug Administration has approved Sarclisa in combination with bortezomib, lenalidomide, and dexamethasone as a first line treatment option for adult patients with newly diagnosed multiple myeloma who are not eligible for autologous stem cell transplant
  • 20 September 2024
    Antiviral-Resistant Variants of SARS-CoV-2 Can Emerge in Immunocompromised People
    Researchers isolated SARS-CoV-2 strains, which are drug resistant with mutations to the nsp12 protein that is the target of remdesivir and another variant with mutations to the nsp5 protein, the target of Paxlovid. These mutations help the virus persist in people with compromised immunity despite common antiviral treatments.
  • 20 September 2024
    NUS scientists discover novel approach to rejuvenate aged egg cells
    Researchers from the Mechanobiology Institute at NUS and the NUS Bia-Echo Asia Centre for Reproductive Longevity and Equality , based at the NUS Yong Loo Lin School of Medicine, have developed an innovative technique to significantly enhance the reproductive potential of aged oocytes, or immature egg cells, potentially paving the way for better outcomes of assisted reproductive technologies, such as in-vitro fertilisation , for older females.
  • 19 September 2024
    Cabinet approves Bio-RIDE scheme to support cutting edge research and development in Biotechnology
    The Union Cabinet, chaired by the Prime Minister Shri Narendra Modi, approved continuation of the two umbrella schemes of Department of Biotechnology , merged as one scheme-‘Biotechnology Research Innovation and Entrepreneurship Development with a new component namely Biomanufacturing and Biofoundry.
  • 19 September 2024
    Indian pharma sector set for 8-10% growth this fiscal

    The Indian pharmaceutical sector is projected to see revenue growth of 8-10% this financial year, driven by strong exports to regulated markets such as the US and Europe, a recovery in semi-regulated markets including Africa and Asia, and consistent domestic demand, according to a CRISIL Ratings report. This forecast follows a successful previous year with approximately 10% growth.

  • 12 September 2024
    Alopexx Announces Collaboration with Bharat Biotech for the Development and Commercialization of Broad-Spectrum Anti-Microbial Vaccine AV0328
    Alopexx, Inc., a clinical-stage biotechnology company focused on developing novel, broad-spectrum immune-mediated therapeutics for the prevention and treatment of bacterial, fungal, and parasitic infections, announced a collaboration with Bharat Biotech for the co-development and commercialization of Alopexxs proprietary broad-spectrum anti-microbial vaccine, AV0328, in India and other low income and lower middle-income countries.
  • 12 September 2024
    Newly Discovered Antimicrobial Could Prevent or Treat Cholera

    More than a million people each year die from infections by pathogens that are resistant to antimicrobials, and the problem is growing. Meanwhile, the discovery of new antimicrobials that can help stem the tide has not kept pace.

  • 12 September 2024
    Lilly expands manufacturing footprint in Ireland with 1.8 billion USD investment
    Eli Lilly and Company announced a 1 billion USD expansion of its Limerick, Ireland, manufacturing site to increase production of biologic active ingredients, including those for its recently approved treatment for early symptomatic Alzheimers disease.
  • 9 September 2024
    Sex hormones modulate the immune system to influence disease risk differently

    Researchers have uncovered how hormones profoundly affect our immune systems, explaining why men and women are affected by diseases differently. 

    Scientists from the Karolinska Institutet in Sweden and Imperial College London have shown for the first time which aspects of our immune systems are regulated by sex hormones, and the impacts this has on disease risk and health outcomes in males and females.

Subscribe to Pharma News

Subscribe with us




 


 

 

Do Not Forget to Verify

(Click on Subscription link in your inbox)

--------

whatsapp

 

Also Join:  youtube  telegram

Clini India

 

CLRI

Jobs by Category

Production Jobs

R&D Jobs

F&D Jobs

Sales & Marketing

QA Jobs

QC Jobs

Faculty Jobs

CRO Jobs

DRA Jobs

IPR Jobs

IT Jobs

Packaging Alerts

Hospital Pharmacist